Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Breast Cancer (ABC) Trial
NCT00002582Phase 3Completed
- Sponsor
- The Institute of Cancer Research
- Start
- Jun 1993
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of cyclophosphamide, methotrexate, fluorouracil, doxorubicin, goserelin in breast cancer, sponsored by The Institute of Cancer Research. Started Jun 1993; status: completed.
02
Drugs
cyclophosphamidemethotrexatefluorouracildoxorubicingoserelin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00002582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002582.